-
The Food and Drug Administration has been without a permanent leader since President Biden took office in January. Califf led the agency during the last year of the Obama administration.
-
Agency officials said reducing the number of doses creates a potential for harm in patients because "they may assume that they are fully protected when they are not" and may "take unnecessary risks."
-
The FDA greenlights the biotech firm's vaccine for emergency use in the U.S. The move bolsters a vast inoculation effort that's already underway.
-
Gov. Ron DeSantis also directed 21,450 doses be sent to the Florida Department of Health to help at long-term care facilities.
-
Gov. DeSantis said he thought HHS, which signed an agreement with Pfizer, would allocate based on states’ so-called at-risk populations. Instead, he said the feds “basically did it on a population basis.”
-
More than half - 97,500 doses - will be sent to five hospitals to be administered to high-contact and high-exposure health care personnel, the governor said.
-
An FDA advisory panel meets to discuss emergency use approval of the coronavirus vaccine.
-
The drug is a combo of two antibodies to enhance the chances it will prove effective. It's an experimental medicine that President Trump was given when he was sickened last month.
-
The Lucira COVID-19 All-In-One Test Kit is expected to provide results in 30 minutes or less. Its approval could help alleviate the strain on the nation's precarious coronavirus testing system.
-
The president-elect. who made the pandemic a linchpin of his campaign, now has the urgent job of filling top health care positions in his administration to oversee the rollout of several coronavirus vaccines.